The settlement is likely to benefit as many as 500,000 residents whether they have insurance or not, and it covers all Lilly brand-name insulin products, Ellison said at a news conference.
Litigation remains pending against two other manufacturers named in the 2018 lawsuit, Sanofi-Aventis and Novo Nordisk.
The American Diabetes Association says more than 8 million Americans use insulin, which the body needs to convert food into energy.
President Joe Biden's 2022 Inflation Reduction Act capped out-of-pocket costs of insulin to people on Medicare to $35 a month, but only for seniors.
Novo Nordisk last year also announced plans for insulin price cuts starting this year.
Persons:
Eli Lilly, Lilly, Keith Ellison, Ellison, ” Ellison, Joe Biden's, Alec Smith, Nicole Smith, Holt, ”
Organizations:
PAUL, —, Sanofi, Aventis, Novo Nordisk, American Diabetes Association, York, Medicare
Locations:
— Minnesota, Minnesota, California , Illinois, Arizona, Utah